Burgeoning Oncology Research to Provide Tailwinds to Gene Therapy Market Growth, Surpassing US$ 10 Billion by 2032: Fact.MR Study

29 Jun 2022
www.biospace.com
Gene TherapyVaccine
North America To Be The Most Lucrative Gene Therapy Landscape, Yielding 56% Revenue “As the incidence of various chronic and lifestyle induced ailments increase, healthcare providers are looking out for advanced gene therapy options to develop effective diagnosis and therapeutics, furthering R&D at various levels,” remarks a Fact.MR analyst. Fact.MR – A Market Research and Competitive Intelligence Provider: The global gene therapy market advocates that the industry is poised to incline at an 18.5% value CAGR from 2022-2032, expected to close at a valuation of US$ 10.1 Billion. As of 2022, the market is poised to reach US$ 1.85 Billion in value terms. Rising quest to search for breakthroughs in medical treatments have been fueling demand for gene therapy of various grades. During the 2015-2021 historical period, the market experienced an incline at a value CAGR of 18.7%, closing at a value of US$ 1.55 Billion. Demand further accelerated during the COVID-19 pandemic, as healthcare providers were scrambling to develop powerful vaccines to counter the outbreak. Moreover, key healthcare providers leveraged advanced gene therapeutics to initiate clinical trials for key drug candidates. For more insights into the Market, Get A Sample of this Report! It is expected that oncology research will likely open up lucrative growth prospects for gene therapy providers. According to Globocan 2020, an estimated 19 million new cancer cases and 9,958,133 cancer deaths were reported worldwide in 2020. Various gene therapy strategies are currently being used in the treatment of cancer. These include anti-angiogenic gene therapy, pro-drug activating suicide gene therapy, immune modulation based on gene therapy, oncolytic virotherapy, gene defect correction/compensation, antisense, genetic manipulation of apoptotic and tumor invasion pathways, and RNAi strategies. Key Takeaways from the Market Study By product, yescarta-based gene therapy is likely to yield 44.5% market revenue until 2032 Luxturna-based gene therapy to garner a 36% revenue share by 2032 Europe to emerge as one of the most opportunistic gene therapy market, inclining at over 19% CAGR APAC market was valued at US$ 351 Million in 2021, poised to flourish at an 18.3% CAGR Global gene therapy market is forecast to grow over 5x from 2022 to 2032 For Comprehensive Insights Ask An Analyst Here Competitive Landscape The global gene therapy market is fiercely competitive, with only a few major players. Companies like Amgen Inc., Bluebird Bio, Gilead Sciences, Inc., Novartis AG, Orchard Therapeutics, Sibiono GeneTech Co. Ltd., Spark Therapeutics (Roche AG), and UniQure N.V., have a sizable market share in the Gene Therapy market. In October 2021, the National Institutes of Health, the United States Food and Drug Administration, ten pharmaceutical companies, and five non-profit organizations announced a collaboration to accelerate the development of gene therapies for the 30 million Americans who suffer from a rare disease. Such initiatives are expected to boost demand for gene therapy. BioMarin Pharmaceutical Inc. reported updates on its investigational gene therapy programs in clinical development in February 2022. The Food and Drug Administration (FDA) issued additional requests to the Company for information needed to resolve the clinical hold of the PHEARLESS Phase 1/2 study of BMN 307 issued in September 2021. Key Segments Covered in Gene Therapy Industry Research Gene Therapy Market by Product: Yescarta-based Gene Therapy Kymriah-based Gene Therapy Luxturna-based Gene Therapy Strimvelis-based Gene Therapy Gendicine Others Gene Therapy Market by Application: Ophthalmology Oncology Adenosine Deaminase/Deficient Severe Combined Immunodeficiency (ADA-SCID) Gene Therapy Market by Region: North America Latin America Europe East Asia South Asia MEA Get Customization on this Report for Specific Research Solutions More Valuable Insights Fact.MR, in its new offering, presents an unbiased analysis of the global gene therapy market, presenting historical analysis from 2015 to 2021 and forecast statistics for the period of 2022-2032. The study reveals essential insights on the basis of product (yescarta, kymriah, luxturna, strimvelis, gendicine and others), and application (ophthalmology, oncology and adenosine deaminase/deficient severe combined immunodeficiency (ADA-SCID)adenosine deaminase/deficient severe combined immunodeficiency (ADA-SCID)) across six major regions (North America, Latin America, Europe East Asia, South Asia & Oceania and Middle East & Africa). Fact.MR’s Domain Knowledge in Healthcare Our healthcare consulting team guides organizations at each step of their business strategy by helping you understand how the latest influencers account for operational and strategic transformation in the healthcare sector. Our expertise in recognizing the challenges and trends impacting the global healthcare industry provides indispensable insights and support - encasing a strategic perspective that helps you identify critical issues and devise appropriate solutions. Check out more studies related to Healthcare Industry, conducted by Fact.MR: Huntington's Disease Treatment Market - Huntington's Disease Treatment Market Analysis by Treatment (Symptomatic Treatment of Huntington's disease, Disease-Modifying Therapies for Huntington's disease), by Region - Global Forecast 2022-2032 Animal Vaccines Market - Animal Vaccines Market Analysis by Product (Attenuated, Recombinant, DNA, Inactivated, Subunit Animal Vaccines), by Animal Type (Livestock, Companion Animal Vaccines), by Route of Administration (Subcutaneous, Intranasal, Intramuscular) & Regional Forecast 2022-2032 Amniotic Membrane Market - Amniotic Membrane Market Analysis by Product (Cryopreserved, Dehydrated Amniotic Membrane), by Application (Surgical Wounds, Ophthalmology), by End Use, by Region - Global Forecast 2022-2032 Mental Health Apps Market - Mental Health Apps Market Analysis by Platform Type (Mental Health Apps for Android, iOS), by Application Type (Depression and Anxiety Management, Stress Management, Meditation Management, Wellness Management), by Region - Global Forecast 2022-2032 Aesthetic Medicine Market - Aesthetic Medicine Market Analysis by Procedure Type (Invasive Procedures, Non-Invasive Procedures), by Region - Global Forecast 2022-2032 Regulatory Affairs Outsourcing Market - Regulatory Affairs Outsourcing Market by Services (Regulatory Consulting Outsourcing, Legal Representation Outsourcing), by Category (Drugs, Biologics), by Indication (Oncology, Neurology, Radiology), by Stage (Pre-Clinical, Clinical), by Company Size, by End Use & Regional Forecast 2022-2032 3D Printing Medical Devices Market - 3D Printing Medical Devices Market Analysis by Product Type (3D Printers, 3D Bio-Printers, Materials, Software & Services), by Technology (Laser Beam Melting, Photo Polymerization, Electron Beam Melting, Droplet Deposition), by Application, by End-User & Regional Forecast 2022-2032 mHealth Apps Market - mHealth Apps Market Analysis by Product Type (Medical Apps [Women's Health Apps, Personal, Health Record Apps, Medication Management Apps, Diagnostic Apps], Fitness Apps [Diet & Nutrition, Exercise & Fitness, Lifestyle & Stress]), by Region - Global Forecast 2022-2032 Biotechnology & Pharmaceutical Services Outsourcing Market - Biotechnology & Pharmaceutical Services Outsourcing Market Analysis by Service (Product Testing & Validation, Training & Education, Product Design & Development, Product Maintenance, Regulatory Affairs, Consulting), by End Use & Region - Global Forecast 2022-2032 Electronic Health Records Market - Electronic Health Records Market Analysis by Product (Client-server-based HER, Web-based HER), by Type (Acute, Ambulatory, Post-acute Electronic Health Records), by Business Model, by End Use, by Region - Global Forecast 2022-2032 About Us: Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner. Contact: Mahendra Singh US Sales Office: 11140 Rockville Pike Suite 400 Rockville, MD 20852 Email: sales@factmr.com Tel: +1 (628) 251-158
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
Drugs
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.